William Blair & Company
BMY icon

William Blair & Company’s Bristol-Myers Squibb BMY Stock Holding History

William Blair & Company’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$25.3M Buy
417,659
+58,735
+16% +$3.42M 0.07% 218
2025
Q4 		$19.4M Sell
358,924
-46,716
-12% -$2.25M 0.05% 240
2025
Q3 		$18.3M Sell
405,640
-53,545
-12% -$2.5M 0.05% 244
2025
Q2 		$21.3M Sell
459,185
-222,590
-33% -$10.9M 0.06% 221
2025
Q1 		$41.6M Sell
681,775
-53,194
-7% -$3.1M 0.13% 152
2024
Q4 		$41.6M Buy
734,969
+198,245
+37% +$11.1M 0.12% 153
2024
Q3 		$27.8M Sell
536,724
-45,435
-8% -$2.13M 0.08% 189
2024
Q2 		$24.2M Sell
582,159
-93,451
-14% -$4.18M 0.07% 200
2024
Q1 		$36.6M Sell
675,610
-188,760
-22% -$9.62M 0.12% 146
2023
Q4 		$44.4M Sell
864,370
-264,198
-23% -$13.9M 0.15% 130
2023
Q3 		$65.5M Sell
1,128,568
-58,545
-5% -$3.59M 0.25% 96
2023
Q2 		$75.9M Sell
1,187,113
-31,934
-3% -$2.14M 0.28% 85
2023
Q1 		$84.5M Buy
1,219,047
+8,053
+0.7% +$568K 0.34% 74
2022
Q4 		$87.1M Sell
1,210,994
-64,269
-5% -$4.85M 0.38% 65
2022
Q3 		$90.7M Buy
1,275,263
+15,960
+1% +$1.16M 0.42% 62
2022
Q2 		$97M Buy
1,259,303
+176,326
+16% +$13.4M 0.43% 54
2022
Q1 		$79.1M Buy
1,082,977
+2,340
+0.2% +$157K 0.28% 87
2021
Q4 		$67.4M Sell
1,080,637
-179,866
-14% -$10.6M 0.21% 111
2021
Q3 		$74.6M Sell
1,260,503
-174,033
-12% -$11.5M 0.25% 93
2021
Q2 		$95.9M Buy
1,434,536
+8,330
+0.6% +$543K 0.33% 70
2021
Q1 		$90M Buy
1,426,206
+30,778
+2% +$1.91M 0.34% 67
2020
Q4 		$86.6M Buy
1,395,428
+60,211
+5% +$3.7M 0.32% 74
2020
Q3 		$80.5M Buy
1,335,217
+93,741
+8% +$5.64M 0.34% 64
2020
Q2 		$73M Buy
1,241,476
+269,624
+28% +$16.1M 0.35% 63
2020
Q1 		$54.2M Buy
971,852
+99,922
+11% +$6.11M 0.34% 64
2019
Q4 		$56M Buy
871,930
+231,285
+36% +$13.2M 0.29% 81
2019
Q3 		$32.5M Sell
640,645
-6,967
-1% -$327K 0.19% 116
2019
Q2 		$29.4M Buy
647,612
+15,398
+2% +$717K 0.17% 130
2019
Q1 		$30.2M Buy
632,214
+31,772
+5% +$1.58M 0.18% 119
2018
Q4 		$31.2M Sell
600,442
-67,639
-10% -$3.63M 0.23% 105
2018
Q3 		$41.5M Sell
668,081
-6,300
-0.9% -$374K 0.25% 98
2018
Q2 		$37.3M Sell
674,381
-43,011
-6% -$2.32M 0.25% 99
2018
Q1 		$45.4M Sell
717,392
-46,085
-6% -$2.96M 0.32% 79
2017
Q4 		$46.8M Buy
763,477
+22,832
+3% +$1.43M 0.32% 82
2017
Q3 		$47.2M Sell
740,645
-14,100
-2% -$823K 0.35% 76
2017
Q2 		$42.1M Sell
754,745
-472,072
-38% -$25.7M 0.32% 81
2017
Q1 		$67.6M Sell
1,226,817
-145,073
-11% -$7.96M 0.55% 46
2016
Q4 		$80.2M Sell
1,371,890
-273,573
-17% -$15M 0.72% 31
2016
Q3 		$88.7M Sell
1,645,463
-144,120
-8% -$9.26M 0.78% 23
2016
Q2 		$132M Buy
1,789,583
+139,767
+8% +$9.88M 1.23% 10
2016
Q1 		$105M Buy
1,649,816
+50,564
+3% +$3.19M 0.99% 16
2015
Q4 		$110M Sell
1,599,252
-331,678
-17% -$21.9M 1.03% 14
2015
Q3 		$114M Sell
1,930,930
-2,240,285
-54% -$142M 0.99% 14
2015
Q2 		$278M Buy
4,171,215
+467,281
+13% +$30.8M 0.42% 40
2015
Q1 		$239M Buy
3,703,934
+166,334
+5% +$10.4M 0.37% 59
2014
Q4 		$209M Buy
3,537,600
+1,910,466
+117% +$108M 0.34% 68
2014
Q3 		$83.3M Buy
1,627,134
+1,016,596
+167% +$50.8M 0.14% 210
2014
Q2 		$29.6M Buy
610,538
+55,178
+10% +$2.72M 0.05% 446
2014
Q1 		$28.9M Buy
555,360
+89,256
+19% +$4.75M 0.05% 449
2013
Q4 		$24.8M Buy
466,104
+82,618
+22% +$4.21M 0.04% 492
2013
Q3 		$17.7M Buy
383,486
+13,643
+4% +$599K 0.03% 540
2013
Q2 		$16.5M Buy
+369,843
New +$16.1M 0.03% 534

Other funds holding BMY

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

William Blair & Company's BMY Position: Q1 2026 in Review

William Blair & Company increased its Bristol-Myers Squibb (BMY) stake by 16% in Q1 2026, buying an estimated $3.42M and bringing the position to 417,659 shares worth $25.3M. The position accounts for 0.07% of the portfolio, ranked #218.

William Blair & Company first reported a position in BMY in Q2 2013 and has held it in 52 quarters since. The position peaked at $278M in Q2 2015. 2,519 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

  • William Blair & Company held 417,659 shares of Bristol-Myers Squibb worth $25.3M as of Q1 2026.
  • William Blair & Company bought 58,735 Bristol-Myers Squibb shares in Q1 2026, an estimated $3.42M.
  • Bristol-Myers Squibb made up 0.07% of William Blair & Company's portfolio in Q1 2026, its #218 holding.
  • William Blair & Company first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 52 quarters since.
  • William Blair & Company's Bristol-Myers Squibb position peaked at $278M in Q2 2015.
  • 2,519 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on William Blair & Company's 13F filing for Q1 2026, filed 8 May 2026.